Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy

被引:108
作者
Vaidya, B
Imrie, H
Perros, P
Dickinson, J
McCarthy, MI
Kendall-Taylor, P
Pearce, SHS [1 ]
机构
[1] Univ Newcastle Upon Tyne, Sch Clin Med Sci, Dept Endocrinol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Freeman Rd Hosp, Endocrine Unit, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England
[3] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[4] St Marys Hosp, Imperial Coll, Sch Med, Div Med,Sect Endocrinol, London W2 1PG, England
基金
英国惠康基金;
关键词
D O I
10.1016/S0140-6736(99)01465-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Smoking and demographic variables are known to be risk factors for the development of thyroid-associated orbitopathy (TAO) among patients with Graves' hyperthyroidism, but a firm genetic basis for TAO has not been established. We show that the presence and severity of TAO are associated with an allele of the cytotoxic T lymphocyte antigen-4-gene.
引用
收藏
页码:743 / 744
页数:2
相关论文
共 5 条
[1]  
BAHN RS, 1993, NEW ENGL J MED, V329, P1468
[2]   AGE AND GENDER INFLUENCE THE SEVERITY OF THYROID-ASSOCIATED OPHTHALMOPATHY - A STUDY OF 101 PATIENTS ATTENDING A COMBINED THYROID EYE CLINIC [J].
PERROS, P ;
CROMBIE, AL ;
MATTHEWS, JNS ;
KENDALLTAYLOR, P .
CLINICAL ENDOCRINOLOGY, 1993, 38 (04) :367-372
[3]   The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus [J].
Vaidya, B ;
Imrie, H ;
Perros, P ;
Young, ET ;
Kelly, WF ;
Carr, D ;
Large, DM ;
Toft, AD ;
McCarthy, MI ;
Kendall-Taylor, P ;
Pearce, SHS .
HUMAN MOLECULAR GENETICS, 1999, 8 (07) :1195-1199
[4]   MODIFICATION OF CLASSIFICATION OF EYE CHANGES OF GRAVES-DISEASE - RECOMMENDATIONS OF AD-HOC COMMITTEE OF AMERICAN THYROID ASSOCIATION [J].
WERNER, SC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1977, 44 (01) :203-204
[5]   CTLA-4 GENE POLYMORPHISM ASSOCIATED WITH GRAVES-DISEASE IN A CAUCASIAN POPULATION [J].
YANAGAWA, T ;
HIDAKA, Y ;
GUIMARAES, V ;
SOLIMAN, M ;
DEGROOT, LJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (01) :41-45